PharmaCom BioVet, Inc.
PharmaCom BioVet, Inc.
Your view on PHMB
Overview
What the company does, where it operates, and who runs it.
About PharmaCom BioVet, Inc.
- Industry
- Medical - Care Facilities
- Sector
- Healthcare
- CEO
- Ira Frohman
- Headquarters
- 6040-A Six Forks Road, Raleigh, NC, US
- Industry
- Medical - Care Facilities
- Sector
- Healthcare
- CEO
- Ira Frohman
- Headquarters
- 6040-A Six Forks Road, Raleigh, NC, US
PharmaCom BioVet, Inc. focuses on operating a network of companion animal cancer treatment centers in the United States. The company focuses on developing bone marrow transplantation and other cancer treatment procedures to benefit companion animals that are diagnosed with lymphoma, other different types of cancers, and other diseases that are incurable. It has licensed a series of proprietary devices and compounds that would reduce suffering in animals with cancer. The company was formerly known as ABV Gold Inc. and changed its name to PharmaCom BioVet, Inc. in August 2008. PharmaCom BioVet, Inc. was incorporated in 1995 and is headquartered in Raleigh, North Carolina.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks the stock is worth vs. the current price.
FRC's fair value estimate for PharmaCom BioVet, Inc., and the rating behind it. PHMB last traded at $0.0001; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for PharmaCom BioVet, Inc.. Starting points for PharmaCom BioVet, Inc.: beta -6.74 — an Medical - Care Facilities name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for PharmaCom BioVet, Inc.. PharmaCom BioVet, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for PharmaCom BioVet, Inc.. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for PharmaCom BioVet, Inc.. PharmaCom BioVet, Inc. has reported as a listed company since 1999. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
PharmaCom BioVet, Inc. valued side by side against its closest peers. PharmaCom BioVet, Inc. is measured against Medical - Care Facilities peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
Which funds and firms own the stock.
Which institutions hold PharmaCom BioVet, Inc., and how their positions are changing. At a $1.1M market value, institutional positions materially move PharmaCom BioVet, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.
Insider Trading
Recent buying and selling by company executives.
Buying and selling by PharmaCom BioVet, Inc. executives and directors. Shares of PharmaCom BioVet, Inc. have traded between $0.0000 and $0.0001 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming PharmaCom BioVet, Inc.. PharmaCom BioVet, Inc. is a $1.1M Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.
House Trading
U.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming PharmaCom BioVet, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals.
News
Latest headlines and market coverage.
Latest headlines and company announcements for PharmaCom BioVet, Inc.. Coverage tracks PharmaCom BioVet, Inc. within Medical - Care Facilities (Healthcare). Press releases and market coverage, newest first.